3 completed, 1 unknown. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Uterine Fibroid: new trials by email Literature Review of Uterine Fibroid trials Research Report on Uterine Fibroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Preoperative Misoprostol in Blood-loss Reduction During Myomectomy. Misoprostol Pfizer Brand, Non-insertion of Misoprostol Pfizer Brand - Uterine Fibroid | Phase 2 / Phase 3 | Unknown | Makerere University | 46 | 2018-01-10 | 2018-04-30 |
| LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Relugolix, Estradiol/norethindrone acetate - Heavy Menstrual Bleeding, Uterine Fibroid | Phase 3 | Completed | Myovant Sciences GmbH | 477 | 2017-10-19 | 2024-05-09 |
| LIBERTY 2: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Relugolix, Estradiol/norethindrone acetate, Relugolix placebo - Heavy Menstrual Bleeding, Uterine Fibroid | Phase 3 | Completed | Myovant Sciences GmbH | 382 | 2017-06-14 | 2022-04-20 |
| LIBERTY 1: Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Relugolix, Estradiol/norethindrone acetate, Estradiol/norethindrone acetate placebo - Heavy Menstrual Bleeding, Uterine Fibroid | Phase 3 | Completed | Myovant Sciences GmbH | 388 | 2017-04-26 | 2022-04-19 |
Leiomyoma (4) · Menorrhagia (3)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Neoplasms, Connective and Soft Tissue (4) · Neoplasms, Muscle Tissue (4) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Hemorrhage (3) · Menstruation Disturbances (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3) · Uterine Diseases (3) · Uterine Hemorrhage (3)
estradiol, norethindrone drug combination (3) · relugolix (3) · Estradiol (2) · Misoprostol (1)
Myovant Sciences GmbH (3) · Makerere University (1)
Brazil (3) · Poland (3) · South Africa (3) · United States (3) · Belgium (2) · Chile (2) · Czechia (2) · Hungary (2) · Italy (2) · Uganda (1) · United Kingdom (1)
Josephat Byamugisha, Professor (1) · Moses Mugisha (1)
PMID 36357960, PMID 37477173, PMID 37863160, PMID 33596357, PMID 35415708, PMID 35675604, PMID 37183454, PMID 39466126, PMID 40320117
2016 (2), 2017 (1)